You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Article metrics

Article menu
Recommendation
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Free

 

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

AbstractFullPdf
Feb 2022583759872864
Mar 2022260326171566
Apr 202214341435811
May 2022181918661132
Jun 202215081567889
Jul 202211001113616
Aug 202214541474622
Sep 202213301334679
Oct 202212161225672
Nov 202210991080611
Dec 20221022988511
Jan 202310931066537
Feb 2023872844472
Mar 2023930891464
Apr 202310511020604
May 202311141109539
Jun 2023779764437
Jul 2023700676423
Aug 2023632590365
Sep 2023805777481
Oct 2023854820502
Nov 2023850778435
Dec 2023813688380
Jan 2024812684454
Feb 2024779740476
Mar 2024916880599
Total334223301318141